![Mark Pavao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Pavao
Director/Miembro de la Junta en
COYA THERAPEUTICS, INC.
.
Perfil
Mark H.
Pavao was the founder of R-Pharm US LLC, founded in 2014, where the titles held included President, Chief Executive Officer & Director.
Current jobs include Independent Director at Coya Therapeutics, Inc. starting in 2026, and Chief Commercial Officer at BioXcel Therapeutics, Inc. starting in 2026.
Former job includes Senior Vice President-Sales & Marketing at NitroMed, Inc.
Cargos activos de Mark Pavao
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Corporate Officer/Principal | 12/01/2026 |
| COYA THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/04/2026 |
Antiguos cargos conocidos de Mark Pavao.
| Empresas | Cargo | Fin |
|---|---|---|
R-Pharm US LLC
 R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Fundador | - |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Ventas & Marketing | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
6
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Health Technology |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Coya Therapeutics, Inc.
 Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
- Bolsa de valores
- Insiders
- Mark Pavao
Elige MarketScreener 
